NASDAQ:IRIX IRIDEX Q3 2026 Earnings Date & Estimates $0.74 -0.01 (-1.83%) Closing price 04:00 PM EasternExtended Trading$0.76 +0.02 (+3.22%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. IRIDEX is estimated to report Q3 2026 earnings on Tuesday, November 17, 2026, after market closes. The conference call is scheduled for November 10, 2026 at 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 17, 2026TimeAfter Market ClosesConference Call DateNovember 10, 2026Conference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from IRIDEX in Q3 2026IRIDEX is expected to post earnings of -$0.04 per share on revenue of $12.65 million. In the same quarter a year earlier IRIDEX reported -$0.09 per share on revenue of $12.48 million. IRIDEX last reported on August 18, 2026, posting -$0.07 per share and missing the -$0.01 consensus estimate. IRIDEX has beaten the consensus EPS estimate in 3 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.04Expected Revenue$12.65 millionPrior-Year EPS-$0.09Prior-Year Revenue$12.48 millionExpected Revenue Growth+1.3%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.07 (Missed by -$0.06)Last Quarter Revenue$12.57 millionEPS Beat Rate3 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report IRIDEX Q3 2026 Earnings FAQ When does IRIDEX report Q3 2026 earnings? IRIDEX (NASDAQ:IRIX) is estimated to report Q3 2026 earnings on Tuesday, November 17, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is IRIDEX's Q3 2026 earnings call? IRIDEX's Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for IRIDEX? Analysts expect IRIDEX to post earnings of -$0.04 per share for Q3 2026. How much revenue is IRIDEX expected to report? The consensus revenue estimate for IRIDEX is $12.65 million for Q3 2026. IRIDEX Earnings HeadlinesIRIDEX (NASDAQ:IRIX) Stock Price Breaks Below 200-Day Moving Average - Here's What HappenedOctober 20, 2026 | americanbankingnews.comIridex Reports Sustained Glaucoma Benefits With MicroPulse Laser Therapy At Two YearsOctober 12, 2026 | rttnews.comElon Musk… A Total Fraud?Jeff Brown, the former tech executive who picked Nvidia in 2016 before it surged as high as 37,800 percent, just got inside Elon Musk's new Cybercab, a vehicle with no steering wheel or pedals. In 2018, the New York Post called Musk a total fraud. Brown's latest footage shows just how far that technology has come since then.October 27 at 1:00 AM | Brownstone Research (Ad)Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication UseOctober 12, 2026 | finance.yahoo.comIridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced GlaucomaOctober 12, 2026 | marketscreener.comMIridex Completes Relocation of Manufacturing Facility to San Jose, CaliforniaOctober 5, 2026 | globenewswire.comSee More IRIDEX Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like IRIDEX? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IRIDEX and other key companies, straight to your email. Email Address About IRIDEXIRIDEX (NASDAQ:IRIX) (NASDAQ: IRIX) develops, manufactures and sells laser-based medical systems and disposable devices used in ophthalmic procedures. Its technologies are designed to help eye-care professionals treat glaucoma, retinal diseases and other conditions affecting vision. The company’s product portfolio includes the Cyclo Glaucoma Laser System, which uses MicroPulse and continuous-wave laser technology for glaucoma treatment, as well as laser systems such as the IRIDEX IQ series for retinal and photocoagulation procedures. IRIDEX also offers procedure-specific probes, delivery devices and other accessories used with its laser platforms. Founded in 1989, IRIDEX serves ophthalmologists, hospitals, ambulatory surgery centers and other health-care providers. The company markets its products in the United States and internationally through a combination of direct sales organizations and distributors.View IRIDEX ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple's Foldable iPhone Sold Out in Minutes, But Wall Street Has QuestionsCoca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest StrengthWhirlpool's Stock Collapse Raises a Bigger Question About Its Recovery PotentialAnalysts Turn Bullish on Meta Platforms Despite Post-Earnings FallLockheed Martin's F-35 Deal Could Change How Wall Street Values the StockIntel's $155 Price Target Raises a Bigger Question About Its Turnaround PotentialMerck and Moderna's Cancer Vaccine Worked—Who Gets Paid? Upcoming Earnings Deutsche Bank Aktiengesellschaft (10/28/2026)UBS Group (10/28/2026)Canadian Pacific Kansas City (10/28/2026)Amazon.com (10/29/2026)Mondelez International (10/29/2026)Starbucks (10/29/2026)BP (10/30/2026)Chevron (10/30/2026)Sanofi (10/30/2026)Canadian National Railway (10/30/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
